Ecovyst (ECVT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Q1 2026 sales rose 50.2% year-over-year to $215 million, driven by higher prices and volumes in regeneration services and virgin sulfuric acid, including contributions from the Waggaman asset acquisition.
Adjusted EBITDA increased 87% year-over-year to $39.8 million, reflecting strong demand, improved pricing, and higher volumes, partially offset by increased manufacturing and transportation costs.
Net income from continuing operations was $5.7 million, reversing a loss of $8.1 million in Q1 2025.
$36 million in share repurchases executed in Q1 2026, with $146 million remaining under authorization.
The divestiture of the Advanced Materials & Catalysts business at year-end 2025 strengthened the balance sheet and enabled greater capital flexibility.
Financial highlights
Sales increased by $71.9 million (50.2%) year-over-year, with volume and price/mix as key drivers.
Adjusted EBITDA margin improved to 18.5%, up 360 basis points from Q1 2025.
Adjusted Free Cash Flow improved to $4.2 million from a $13 million use in Q1 2025.
Net debt leverage ratio at quarter end was 1.2x, unchanged from year-end.
Liquidity stood at $237 million as of March 31, 2026.
Outlook and guidance
Full-year 2026 sales guidance raised to $890–$970 million, reflecting higher sulfur cost pass-through.
Adjusted EBITDA guidance raised to $180–$195 million; adjusted free cash flow to $40–$55 million.
Q2 and Q3 2026 adjusted EBITDA expected at $50–$55 million per quarter; Q4 at $40–$45 million.
Guidance assumes higher sulfur prices and increased pass-through costs; excludes Calabrian acquisition impact.
Calabrian acquisition expected to close by end of Q2 2026, with pro-forma net debt leverage ratio projected at ~2x.
Latest events from Ecovyst
- Annual meeting to elect directors, approve pay, ratify auditor, and highlight ESG progress.ECVT
Proxy filing15 Apr 2026 - Innovation, sustainability, and strong demand drive growth and shareholder value.ECVT
CL King's 22nd Annual Best Ideas Conference 202414 Mar 2026 - Strong 2025 growth, major divestiture, debt reduction, and robust 2026 outlook.ECVT
Q4 202526 Feb 2026 - Q2 2024 net income dropped 68% and guidance was lowered as catalyst demand softened.ECVT
Q2 20242 Feb 2026 - Q3 sales up 3.4% to $179.2M, with resilient Ecoservices and steady full-year guidance.ECVT
Q3 202417 Jan 2026 - Q3 2024 saw robust cash flow, margin expansion, and a strategic focus on sustainability.ECVT
Bank of America Securities 2024 Leveraged Finance Conference12 Jan 2026 - Q4 growth in core segments, 2025 sales and EBITDA to rise despite Zeolyst JV impairment.ECVT
Q4 202423 Dec 2025 - $556M deal boosts catalyst capabilities, recurring revenue, and global reach.ECVT
M&A Announcement16 Dec 2025 - Annual meeting to vote on directors, pay, auditor, with focus on governance and sustainability.ECVT
Proxy Filing1 Dec 2025